Motor function improved with a favorable safety profile for patients with Parkinson’s disease who used tavapadon while receiving oral levodopa, according to a study published in JAMA Neurology.This ...

Solengepras, a once-daily, oral, non-dopaminergic GPR6 inhibitor, demonstrated meaningful reductions in daily OFF time and ...

Over the past decade in the United States, cannabis use has risen dramatically, with daily or near-daily consumption now affecting an estimated 18 million ...

Alpha synuclein is a presynaptic protein that, when misfolded, contributes to neuronal degeneration and the progression of ...

For decades, the scientific theory of depression focused on chemicals — serotonin, norepinephrine and dopamine. Nearly every ...

New Book Addicted to Failure Exposes Why the $42 Billion Recovery Industry Profits From Relapse and Introduces the ...

This narrative review examines evidence linking Attention-Deficit/Hyperactivity Disorder (ADHD) and long-term brain health, ...

An experimental opioid alternative called DFNZ achieved effective pain relief in mice without addiction risk or breathing ...

AI prediction loops exploit uncertainty, deepen dopamine dependence, and reshape anticipation, decisions, and control ...

Once viewed only as power generators, mitochondria are now understood to play a role in mental illness. Their ability to ...

Experts at NAPNAP 2026 emphasize the need for school-based interventions to address ongoing alcohol and marijuana use among diverse high school populations.

Detailed results from the phase 3 TEMPO trials show tavapadon offers a mechanistically distinct approach for managing motor ...